CA eHealth Performance Manager up to 6.3.2.12 Shared Object RPATH untrusted search path
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 7.3 | $0-$5k | 0.00 |
Summary
A vulnerability labeled as critical has been found in CA eHealth Performance Manager up to 6.3.2.12. Affected by this issue is some unknown functionality of the component Shared Object Handler. Executing a manipulation of the argument RPATH can lead to an unknown weakness. This vulnerability is tracked as CVE-2021-28246. The attack can be launched remotely. No exploit exists.
Details
A vulnerability has been found in CA eHealth Performance Manager up to 6.3.2.12 and classified as critical. This vulnerability affects an unknown part of the component Shared Object Handler. The manipulation of the argument RPATH with an unknown input leads to a unknown weakness. The CWE definition for the vulnerability is CWE-426. The product searches for critical resources using an externally-supplied search path that can point to resources that are not under the product's direct control. As an impact it is known to affect confidentiality, integrity, and availability. CVE summarizes:
CA eHealth Performance Manager through 6.3.2.12 is affected by Privilege Escalation via a Dynamically Linked Shared Object Library. A regular user must create a malicious library in the writable RPATH, to be dynamically linked when the emtgtctl2 executable is run. The code in the library will be executed as the ehealth user. NOTE: This vulnerability only affects products that are no longer supported by the maintainer
The weakness was disclosed 03/26/2021. The advisory is shared for download at n4nj0.github.io. This vulnerability was named CVE-2021-28246. There are known technical details, but no exploit is available. The current price for an exploit might be approx. USD $0-$5k (estimation calculated on 08/04/2024). The MITRE ATT&CK project declares the attack technique as T1574.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
VulDB is the best source for vulnerability data and more expert information about this specific topic.
Product
Vendor
Name
Version
License
Website
- Vendor: https://www.ca.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 7.3VulDB Meta Temp Score: 7.3
VulDB Base Score: 6.3
VulDB Temp Score: 6.2
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 7.8
NVD Vector: 🔍
CNA Base Score: 7.8
CNA Vector: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Untrusted search pathCWE: CWE-426
CAPEC: 🔍
ATT&CK: 🔍
Physical: Partially
Local: Yes
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
03/12/2021 🔍03/26/2021 🔍
03/26/2021 🔍
08/04/2024 🔍
Sources
Vendor: ca.comAdvisory: n4nj0.github.io
Status: Not defined
CVE: CVE-2021-28246 (🔍)
GCVE (CVE): GCVE-0-2021-28246
GCVE (VulDB): GCVE-100-171832
Entry
Created: 03/26/2021 14:49Updated: 08/04/2024 00:42
Changes: 03/26/2021 14:49 (36), 04/05/2021 17:49 (5), 04/05/2021 17:55 (20), 06/05/2024 11:36 (18), 08/04/2024 00:42 (11)
Complete: 🔍
Cache ID: 216::103
VulDB is the best source for vulnerability data and more expert information about this specific topic.
No comments yet. Languages: en.
Please log in to comment.